DOH reviewing different dengue vaccines; Dengvaxia still need to apply for new license | Inquirer News

DOH reviewing different dengue vaccines; Dengvaxia still need to apply for new license

/ 08:10 PM August 19, 2022

Dengue vaccine

Dengvaxia still needs to apply for a new license. FILE PHOTO

MANILA, Philippines — In light of the continuous rise of dengue cases in the country, the Department of Health (DOH) officer-in-charge Maria Rosario Vergeire on Friday said the agency is reviewing different kinds of vaccines available for dengue.

Dengvaxia, on the other hand, needs to apply for a certificate of product registration (CPR) from the Food and Drug Administration, according to Vergeire.

Article continues after this advertisement

Dengvaxia’s vaccine license was revoked after being linked to the deaths of several children, according to Vergeire.

FEATURED STORIES

“In order for us para magamit ang bakuna na ito, kailangan (to use this vaccine) the manufacturers will undergo or go through these processes of applying for the CPR and then kailangan ma-evaluate ulit ng ating (it has to be evaluated by) health technology council,” Vergeire said of the dengvaxia vaccine.

“But while waiting for that, of course, the Department of Health, together with our experts, are already reviewing the different vaccines available against dengue,” she added.

Article continues after this advertisement

Vergeire noted that Dengvaxia’s CPR was revoked due to non-compliance with the requirements of the FDA.

Article continues after this advertisement

In late 2017, the DOH halted its massive anti-dengue immunization program using Dengvaxia after its manufacturer Sanofi Pasteur said patients who got vaccinated but had no prior exposure to the virus could suffer severe symptoms.

Article continues after this advertisement

The Public Attorney’s Office filed complaints against health officials for the deaths of children allegedly caused by the anti-dengue vaccine, which is being widely used in other countries worldwide.

But in January 2019, DOH said no death was confirmed to have been directly caused by Dengvaxia.

Article continues after this advertisement

Meanwhile, nine out of 17 regions have reported an increase of dengue cases in the country, according to Vergeire. She didn’t elaborate on which regions were included.

Vergeire also said the country logged 23,414 dengue cases based on reports from July 3, 2022 to July 30, 2022, of whom, 18,208 or 78 percent of the dengue cases have been hospitalized.

RELATED STORIES:

PH needs vaccine for dengue as disease remains a threat despite drop in cases – expert

Palace: Dengvaxia issue ‘influencing’ Filipinos’ hesitancy over COVID jabs

JMS/abc
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: dengue, Dengvaxia

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.